by Jessi O'Connell | Jan 15, 2026 | Insights
The pharmaceutical and medical device supply chain looks very different today than it did even a decade ago. What was once a more linear path from manufacturer to distributor has evolved into a highly interconnected network of partners, facilities, and outsourced...
by Jessi O'Connell | Jan 8, 2026 | Insights
As the pharmaceutical and medical device industries move into 2026, compliance teams are facing a familiar reality with a new level of intensity. Regulatory expectations continue to expand, supply chains are more complex than ever, and state-level compliance...
by Jessi O'Connell | Dec 17, 2025 | Insights
As the year comes to a close, many pharmaceutical and medical device companies are focused on budgets, forecasts, and strategic planning. Too often state licensing and regulatory compliance is only addressed reactively once renewal notices arrive or issues surface....
by Jessi O'Connell | Dec 10, 2025 | Insights
Legal teams that advise pharmaceutical and medical device companies are taking on more responsibility each year as regulatory expectations grow across federal, state, and territorial agencies. Whether your firm handles mergers and acquisitions, stock sales, corporate...
by Jessi O'Connell | Dec 4, 2025 | Insights
A practical guide for compliance and licensing managers in pharmaceutical and medical device distribution Managing licenses for a pharmaceutical or medical device wholesaler is never simple. Every state has its own rules, timelines, interpretations, and expectations....
by Jessi O'Connell | Nov 24, 2025 | Insights
The pharmaceutical supply chain has become more complex than ever. Manufacturers, virtual manufacturers, CMOs, and CDMOs rely heavily on third party logistics providers to manage distribution, storage, and transportation of finished goods. This networked model...
